Fluorescence In situ Hybridization Probe Market Report 2024 (Global Edition)

Global Fluorescence In situ Hybridization Probe Market Report 2024 Market Size Split by Technology (Flow FISH, Q FISH, Other FISH), by Type (DNA, RNA, mRNA, miRNA, Other), by Application (Cancer Resea...

Fluorescence In situ Hybridization Probe Market Report Description

We have various report editions of Fluorescence In situ Hybridization Probe Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Fluorescence In situ Hybridization Probe Market Insights Video

Competitive Landscape of the Fluorescence In situ Hybridization Probe Market

The competitive landscape of the Fluorescence In situ Hybridization Probe Market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players include Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Bio-Rad Laboratories, which dominate through extensive product portfolios, robust distribution networks, and advanced technological capabilities. Abbott Laboratories is noted for its comprehensive range of FISH probes used in oncology and genetic testing. Thermo Fisher Scientific leverages its strong market presence and broad capabilities in molecular diagnostics.

Top Companies Market Share in Fluorescence In situ Hybridization Probe Industry: (In no particular order of Rank)

• Thermo Fisher Scientific Inc.
• Perkinelmer Inc.
• BioDot
• Horizon Diagnostics
• Agilent Technologies
• Inc.
• Abnova Corporation
• LGC Biosearch Technologies
• Genemed Biotechnologies
• Inc.
• Oxford Gene Technology IP Limited
• Biocare Medical
• LLC.
• QIAGEN (Exiqon A/S)
• GSP Research Institute
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Fluorescence In situ Hybridization Probe Market

Which Region Dominates the Fluorescence In situ Hybridization Probe Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the advanced healthcare infrastructure, substantial investments in research and development, and a high prevalence of genetic disorders and cancers, which necessitate precise diagnostic tools. In the United States, which dominates the North American market, the demand for FISH probes is fueled by the increasing adoption of personalized medicine and targeted therapies. The presence of numerous biotechnology and pharmaceutical companies, along with leading research institutions, also plays a crucial role in market expansion. Additionally, government initiatives and funding aimed at enhancing diagnostic capabilities contribute to the market's robust growth.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Fluorescence In situ Hybridization Probe Market due to several compelling reasons. ?The Rapid advancements in healthcare infrastructure and increased investment in research and development are driving market expansion. Countries such as China, Japan, and India are at the forefront, leveraging their robust biotechnology and pharmaceutical industries to advance FISH probe technologies. China's aggressive push towards modernizing its healthcare sector, coupled with substantial government funding for precision medicine, has positioned it as a major player in the market. Japan, with its advanced healthcare system and a strong focus on cancer research, is also contributing significantly to the market's growth. India's growing biotechnology sector, supported by favorable government policies and increasing healthcare expenditure, is boosting demand for FISH probes in diagnostic and research applications.

 

The current report Scope analyzes Fluorescence In situ Hybridization Probe Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Fluorescence In situ Hybridization Probe Market

According to Cognitive Market Research, the global Fluorescence In situ Hybridization Probe Market size was estimated at USD 865.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 346.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Fluorescence In situ Hybridization Probe Market with a market size of USD 273.06 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The Rising applications in personalized medicine and targeted therapies also bolster market growth.
• The Canada Fluorescence In situ Hybridization Probe Market had a market share of USD 41.53 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada's Technological innovations in probe design and improved accessibility of sophisticated diagnostic techniques also support the market's development.
• The Mexico Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 31.49 million in 2024.

Europe Fluorescence In situ Hybridization Probe Market

According to Cognitive Market Research, the global Fluorescence In situ Hybridization Probe Market size was estimated at USD 865.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 259.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

• The United Kingdom Fluorescence In situ Hybridization Probe Market had a market share of USD 43.61 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, the market is bolstered by rising awareness among healthcare professionals and patients about genetic testing's benefits, leading to higher adoption rates.
• The France Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 23.88 million in 2024.
• According to Cognitive Market Research, the German fluorescence In situ Hybridization Probe Market size was valued at USD 51.39 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, increasing demand for personalized medicine and targeted therapies fuels the adoption of FISH probes for genetic analysis and diagnostics.
• The Italy Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 22.32 million in 2024.
• The Russia Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 40.23 million in 2024.
• The Spain Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 21.28 million in 2024
• The Luxembourg Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 8.05 million in 2024.
• The Portugal Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 5.45 million in 2024.
• The Greece Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 3.11 million in 2024.
• Rest of Europe's Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 40.23 million in 2024.

Asia Pacific Fluorescence In situ Hybridization Probe Market

According to Cognitive Market Research, the global Fluorescence In situ Hybridization Probe Market size was estimated at USD 865.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 199.0million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Fluorescence In situ Hybridization Probe Market size was valued at USD 89.55 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Automated Storage And Retrieval Systems sales surge in China’s Government initiatives promoting healthcare infrastructure development and research funding further stimulate market growth..
• The Japan Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 27.46 million in 2024.
• The India Fluorescence In situ Hybridization Probe Market had a market share of USD 23.88 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. India's Advancements in healthcare infrastructure and rising awareness among healthcare professionals about FISH technology's benefits have further fueled market expansion.
• The South Korea Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 19.90 million in 2024.
• The Australia Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 10.35 million in 2024.
• The South East Asia Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 13.73 million in 2024.
• The Rest of the Asia Pacific Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 14.13 million in 2024.

South America Fluorescence In situ Hybridization Probe Market

According to Cognitive Market Research, the global Fluorescence In situ Hybridization Probe Market size was estimated at USD 865.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 43.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Fluorescence In situ Hybridization Probe Market size was valued at USD 18.52 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. The growing adoption of personalized medicine and targeted therapies also fuels demand for FISH probes.
• Argentina Fluorescence In situ Hybridization Probe Market had a market share of USD 7.27 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Argentina's growing investments in biotechnology and medical research bolster market growth, along with advancements in healthcare infrastructure..
• Colombia Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 3.85 million in 2024.
• Peru Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 3.55 million in 2024.
• Chile Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 32.22 million in 2024.
• The Rest of Latin America Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 6.96 million in 2024.

Middle East and Africa Fluorescence In situ Hybridization Probe Market

According to Cognitive Market Research, the global Fluorescence In situ Hybridization Probe Market size was estimated at USD 865.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 17.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

• The GCC Countries Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 7.41 million in 2024. Supportive government policies and funding for biotechnology and life sciences research further fuel market growth.
• The Egypt Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 1.82 million in 2024.
• The South Africa Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 2.73 million in 2024. Expanding healthcare infrastructure and rising investments in biotechnology and genomics research support market growth.
• The Turkey Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.49 million in 2024.
• The Nigeria Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 1.82 million in 2024.
• The Rest of the MEA Fluorescence In situ Hybridization Probe Market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 2.04 million in 2024.

Fluorescence In situ Hybridization Probe Market Analysis

Fluorescence In situ Hybridization Probe Market Technology Segment Analysis

According to Cognitive Market Research, Flow FISH, also known as flow cytometry FISH, combines the principles of FISH with flow cytometry to enable the detection and analysis of specific nucleic acid sequences within cells. This technique is particularly advantageous for its ability to provide quantitative data on the number of target sequences present, making it invaluable in research areas such as oncology and microbiology. Flow FISH's capacity for high-throughput analysis and its sensitivity in detecting low-abundance targets further enhance its utility in clinical diagnostics, particularly in identifying genetic abnormalities and assessing disease progression.

Q FISH, or quantitative FISH, focuses on measuring the absolute number of nucleic acid targets within a cell or tissue sample. It leverages advanced imaging and analysis techniques to quantify fluorescence signals, providing researchers and clinicians with precise data on gene copy numbers and structural variations. Q FISH plays a crucial role in genetic research, particularly in studying chromosomal abnormalities, gene amplifications, and in situ gene expression profiling.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Fluorescence In situ Hybridization Probe Industry. Request a Free Sample PDF!

Fluorescence In situ Hybridization Probe Market Type Segment Analysis

According to Cognitive Market Research, DNA technologies are primarily focused on genetic analysis, including sequencing, genotyping, and genetic engineering. The market for DNA-based relay technologies encompasses applications in personalized medicine, agriculture (crop improvement and GMOs), forensic science, and infectious disease diagnostics. Key technologies include PCR (Polymerase Chain Reaction), DNA microarrays, and CRISPR/Cas9 gene editing systems. The DNA segment is driven by the increasing demand for genetic information for both research and clinical applications.

The fastest-growing category in the Fluorescence In situ Hybridization Probe Market is RNA technologies are diverse, covering gene expression analysis, RNA interference (RNAi), RNA sequencing (RNA-seq), and mRNA-based therapeutics (like mRNA vaccines). The market for RNA-based relay technologies is expanding rapidly due to the rise of RNA therapeutics and the growing importance of RNA in understanding gene regulation and disease mechanisms. Applications include cancer research, infectious disease diagnostics (like COVID-19 testing), and neurobiology.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Fluorescence In situ Hybridization Probe Application Segment Analysis

According to Cognitive Market Research, the dominating category is Cancer Research encompasses a broad spectrum of activities, ranging from basic research into molecular mechanisms to clinical trials testing new therapies. Key drivers in this segment include rising cancer incidence rates globally and driving demand for innovative diagnostics and treatments. Market players focus on developing targeted therapies and personalized medicine approaches, leveraging advancements in genomics and biotechnology.

The fastest-growing category in the Fluorescence In situ Hybridization Probe Market is the Genetic Diseases segment targets conditions rooted in genetic mutations or anomalies. This area encompasses a wide range of disorders, from rare genetic syndromes to more prevalent conditions like cystic fibrosis and sickle cell disease. Market dynamics are influenced by breakthroughs in gene therapy, genome editing technologies like CRISPR, and expanded newborn screening programs.

• Cancer Research
• Lung
• Breast
• Bladder
• Hematological
• Gastric
• Prostrate
• Cervical
• Other
• Genetic Diseases
• Other

Fluorescence In situ Hybridization Probe End-Use Segment Analysis

According to Cognitive Market Research, the dominating category is Research-oriented relays are predominantly utilized in laboratory settings and experimental environments. These relays are designed to meet the stringent demands of scientific investigation, offering precise control, minimal interference, and often specialized features such as low noise and high reliability. Researchers rely on these relays to accurately manage and switch electrical signals in various experimental setups, ensuring the integrity and reproducibility of their findings.

The fastest-growing category in the Fluorescence In situ Hybridization Probe Market is Clinical relays play a crucial role in medical applications, where reliability and safety are paramount. These relays are integral to medical equipment such as diagnostic devices, patient monitoring systems, and therapeutic apparatus. They are engineered to operate flawlessly under stringent conditions, adhering to rigorous regulatory standards to guarantee patient safety and diagnostic accuracy. Clinical relays ensure seamless functionality in medical settings, facilitating accurate data acquisition and treatment delivery.

• Research
• Clinical
• Companion diagnostics

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion